Corynebacterium diphtheriae
USMLE Step 1 trap: Confuses diphtheria toxin's target (EF-2) with RNA polymerase inhibition. Diphtheria toxin ADP-ribosylates EF-2 (elongation factor 2), halting protein synthesis at the translocation step.
Corynebacterium diphtheriae is a gram-positive rod that causes diphtheria — classically presenting with a tough gray pseudomembrane in the throat, fever, and the risk of airway obstruction, and USMLE Step 1 tests it from three angles. The most commonly tested management error: in a vignette of active diphtheria, antitoxin must come before antibiotics — antibiotics stop the factory, but antitoxin intercepts the toxin already in flight. The bacterium itself doesn't invade; all the serious damage comes from its exotoxin (ADP-ribosylation of EF-2, halting protein synthesis). If you only memorize 'gram-positive rod, diphtheria,' you will miss the questions on mechanism and treatment priority.
The toxin mechanism is the highest-yield detail here. The toxin is encoded by a bacteriophage and works by ADP-ribosylating EF-2 (elongation factor 2), which shuts down protein synthesis at the translocation step. This affects all nucleated cells — hence myocarditis and peripheral neuropathy are classic complications, not just throat findings. Step 1 loves asking about the mechanism in the context of a patient with cardiac arrhythmia or palatal palsy weeks after a throat infection.
What makes this concept tricky is that students conflate multiple wrong models at once. They mix up the toxin's target with other toxins (Pseudomonas exotoxin A has the same mechanism — ADP-ribosylation of EF-2 — so know both). They forget that diagnosis requires more than a Gram stain. And in a clinical vignette about active diphtheria, they instinctively reach for antibiotics first, which is wrong — antitoxin is the urgent priority because antibiotics cannot neutralize toxin that's already been released.
Common misconceptions
What the exam tests
- Toxin mechanism: Given a description of diphtheria toxin's effect, identify that it ADP-ribosylates EF-2 to halt protein synthesis at translocation — and distinguish this from RNA polymerase inhibition or other mechanisms.
- Clinical complications from toxin: Recognize that myocarditis and demyelinating neuropathy (e.g., palatal palsy, oculomotor palsy) are systemic effects of diphtheria toxin on nucleated cells, not just local throat findings.
- Laboratory diagnosis: Know that C. diphtheriae requires metachromatic granule staining (Albert or Loeffler stain) and that toxin production is confirmed with the Elek test — Gram stain morphology alone is insufficient.
- Management priority: In a vignette of active diphtheria, correctly identify antitoxin as the immediate priority over antibiotics, and understand that penicillin or erythromycin is adjunctive to eliminate the organism and stop further toxin production.
- Prevention: Understand that diphtheria is vaccine-preventable (DTaP/Tdap), and that the toxoid vaccine induces immunity against the toxin, not the organism itself.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →